| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/1997 | US5668104 Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo |
| 09/16/1997 | US5668013 Antigen recognized by patients with antibody associated paraneoplastic cerebellar degeneration, DNA encoding same and uses thereof |
| 09/16/1997 | US5668012 Platelet endothelial cell adhesion molecule-1 promoters and uses thereof |
| 09/16/1997 | US5668007 Recombinant 21 kD cocoa protein and precursor |
| 09/16/1997 | US5668006 Somatostatin receptors |
| 09/16/1997 | US5668005 Cloned genes encoding reverse transcriptase lacking RNASE H activity |
| 09/16/1997 | US5668002 DNA and polypeptide for tumor-associated antigen CO-029 |
| 09/16/1997 | US5667997 Biosynthesis of medium chain fatty acids |
| 09/16/1997 | US5667993 Primers and probes for the identification of bacillus thuringiensis genes and isolates |
| 09/16/1997 | US5667992 Mammalian expression systems for HCV proteins |
| 09/16/1997 | US5667991 Recombinant mersacidin and a method for production |
| 09/16/1997 | US5667989 Fungal cell wall Protein CLY4 |
| 09/16/1997 | US5667988 Gene expression and genes with antibodies and antigens |
| 09/16/1997 | US5667987 P53 response genes |
| 09/16/1997 | US5667986 Yeast promoter for expressing heterologous polypeptides |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667978 Antibody to the neural cell adhesion molecule and methods of use |
| 09/16/1997 | US5667965 Papillomavirus E2 trans-activation repressors |
| 09/16/1997 | US5667839 Human recombinant collagen in the milk of transgenic animals |
| 09/16/1997 | US5667811 Na-K-ATPase inhibiting natriuretic substances |
| 09/16/1997 | US5667797 Anti-viral composition and kit and use for treating rotavirus infection and diarrhea |
| 09/16/1997 | US5667787 Purification of a pertussis outer membrane protein |
| 09/16/1997 | US5667782 Multiple particulate antigen delivery system |
| 09/16/1997 | US5667780 Sensory and motor neuron derived factor and binding |
| 09/16/1997 | US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/16/1997 | US5667491 Method for rapid temporal control of molecular transport across tissue |
| 09/16/1997 | CA2011008C Egf variants and pharmaceutical use thereof |
| 09/16/1997 | CA1339466C Vaccine |
| 09/16/1997 | CA1339465C Electrochemiluminescent assays |
| 09/16/1997 | CA1339464C ¬leu13| motilin, dnas coding for same and methods for producing same |
| 09/13/1997 | CA2175549A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/12/1997 | WO1997032993A1 Chemotactic cytokine iii |
| 09/12/1997 | WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032987A1 Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization |
| 09/12/1997 | WO1997032984A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 09/12/1997 | WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | WO1997032982A1 Human adhesion molecule occludin |
| 09/12/1997 | WO1997032981A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | WO1997032980A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | WO1997032978A1 Production of human hemoglobin in transgenic animals |
| 09/12/1997 | WO1997032971A1 Gene that imparts selective proliferative activity |
| 09/12/1997 | WO1997032900A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 09/12/1997 | WO1997032899A1 Receptor derived peptides involved in modulation of response to ligand binding |
| 09/12/1997 | WO1997032898A1 Anti-inflammatory crf analogs, their compositions and use |
| 09/12/1997 | WO1997032897A1 Novel radioactive peptides useful for screening endothelin-converting enzyme inhibitors |
| 09/12/1997 | WO1997032896A1 Antitumor substance extracted from hen-of-the-woods |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032893A1 Purification method |
| 09/12/1997 | WO1997032891A2 Conjugate for modifying interactions between proteins |
| 09/12/1997 | WO1997032654A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032605A1 Cytomegalovirus nucleic acids encoding proteins having normal or altered class i mhc binding and treatment of diseases |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997032601A1 Method of screening apoptosis inducing substances |
| 09/12/1997 | WO1997032600A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/12/1997 | WO1997032595A1 Method for treatment of insulin resistance |
| 09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | WO1997026320A3 Product for inhibition of attachment of h. influenzae to human cells |
| 09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 09/12/1997 | WO1997024436A3 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
| 09/12/1997 | WO1997023624A3 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 09/12/1997 | WO1997023598A3 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
| 09/12/1997 | WO1997017455A3 Commercial production of avidin in plants |
| 09/12/1997 | WO1997012636A3 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
| 09/12/1997 | CA2248878A1 Gene that imparts selective proliferative activity |
| 09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | CA2248555A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | CA2248255A1 Receptor derived peptides involved in modulation of response to ligand binding |
| 09/12/1997 | CA2248095A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | CA2247817A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | CA2247615A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/10/1997 | EP0794257A1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino aced sequence and vaccine containing same |
| 09/10/1997 | EP0794255A2 Method for cleaving chimeric protein using processing enzyme |
| 09/10/1997 | EP0793728A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 09/10/1997 | EP0793727A1 Production of variant nisin |
| 09/10/1997 | EP0793723A2 New staphylokinase derivatives |
| 09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
| 09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/10/1997 | EP0793720A2 Hemoglobin receptors from neisseriae |
| 09/10/1997 | EP0793717A1 Oral immunization with transgenic plants |
| 09/10/1997 | EP0793713A1 Adeno-associated derived vector systems for gene delivery and integration into target cells |
| 09/10/1997 | EP0793677A1 Anti-inflammatory cd14 polypeptides |
| 09/10/1997 | EP0793676A1 Novel membrane proteins of helicobacter pylori |
| 09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 09/10/1997 | EP0793672A1 Expressed chemokines, their production and uses |
| 09/10/1997 | EP0793506A1 Cellular and serum protein anchors and conjugates |
| 09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
| 09/10/1997 | EP0793503A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 09/10/1997 | EP0793502A1 Novel hedgehog-derived polypeptides |
| 09/10/1997 | EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells |